Evidence map›Paper›PMID 23403681›Full record

ArticleJAMA2013

Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children.

Pål Surén, Christine Roth, Michaeline Bresnahan, Margaretha Haugen, Mady Hornig, Deborah Hirtz, Kari Kveim Lie, W Ian Lipkin, Per Magnus, Ted Reichborn-Kjennerud and 5 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in JAMA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03269110 (Folic Acid Clinical Trial), which is not on this map. Cited by 238 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
238citing papers in PubMed, 14 pooled it
37.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03269110 completednot on this mapstarted 2017, after this paper: background citation

Folic Acid Clinical Trial: Follow up of Children (FACT 4 Child)

TypeobservationalSponsorOttawa Hospital Research InstituteRan2017 to 2023Enrolled664ConditionsAutism Spectrum Disorder, Asthma, Executive Dysfunction, Emotional ProblemArmsSRS 2, CBCL, BRIEF-P
3 · Its place in the literature

Who cites it

238 citing papers in PubMed, 14 syntheses or guidelines pooled it, 533 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Association of the Maternal Folic Acid Supplementation with the Autism Spectrum Disorder: A Systematic Review.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2021
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Maternal Dietary Factors and the Risk of Autism Spectrum Disorders: A Systematic Review of Existing Evidence.Autism research : official journal of the International Society for Autism Research · 2020
    Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

178 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 3 countries.

Pål SurénNorwegian Institute of Public Health, PO Box 4404, Nydalen, N-0403 Oslo, Norway. pal.suren@fhi.no
Christine Roth
Michaeline Bresnahan
Margaretha Haugen
Mady Hornig
Deborah Hirtz
Kari Kveim Lie
W Ian Lipkin
Per Magnus
Ted Reichborn-Kjennerud
Synnve Schjølberg
George Davey Smith
Anne-Siri Øyen
Ezra Susser
Camilla Stoltenberg
Columbia University · USNorwegian Institute of Public Health · NOUniversity College London · GBUniversity of Bergen · NOUniversity of Oslo · NO

Funding

Gene-Environment Interactions in an Autism Birth CohortU01NS047537 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIPKIN, W. IAN · 2003 to 2013
$27.0M
Medical Research Council G9815508NIEHS NIH HHS N01 ES075558NIEHS NIH HHS N0-ES-75558NINDS NIH HHS NS47537NINDS NIH HHS U01 NS047537
6 · The paper itself

Abstract

importancePrenatal folic acid supplements reduce the risk of neural tube defects in children, but it has not been determined whether they protect against other neurodevelopmental disorders.

objectiveTo examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disorder, Asperger syndrome, pervasive developmental disorder-not otherwise specified [PDD-NOS]) in children. DESIGN, SETTING, AND PATIENTS: The study sample of 85,176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity.

main outcome measureSpecialist-confirmed diagnosis of ASDs.

resultsAt the end of follow-up, 270 children in the study sample had been diagnosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS. In children whose mothers took folic acid, 0.10% (64/61,042) had autistic disorder, compared with 0.21% (50/24,134) in those unexposed to folic acid. The adjusted OR for autistic disorder in children of folic acid users was 0.61 (95% CI, 0.41-0.90). No association was found with Asperger syndrome or PDD-NOS, but power was limited. Similar analyses for prenatal fish oil supplements showed no such association with autistic disorder, even though fish oil use was associated with the same maternal characteristics as folic acid use. CONCLUSIONS AND RELEVANCE: Use of prenatal folic acid supplements around the time of conception was associated with a lower risk of autistic disorder in the MoBa cohort. Although these findings cannot establish causality, they do support prenatal folic acid supplementation.

Indexed as

Prenatal Exposure Delayed EffectsAdolescentChildChild Development Disorders, PervasiveChild, PreschoolCohort StudiesDietary SupplementsFemaleFolic AcidHumansMaleNorwayOdds RatioPregnancyPregnancy Trimester, FirstPrenatal CareFolic AcidVitamin B Complex

Identifiers

PMID23403681
PMCPMC3908544
OpenAlexW2113172416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.